Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-144-SR(6M) vs TAP-144-SR(3M) in Premenopausal Breast Cancer
NCT01546649Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2012
- Primary completion
- Dec 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in breast cancer, sponsored by Takeda. Started Apr 2012; status: completed.
02
Drugs
leuprolide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01546649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01546649.